Latest filing published 01 Apr 2026 for HARVARD BIOSCIENCE INC. Read the official filing
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Mark T. Frost, listed as finance chief, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Fathom Digital Manufacturing Corp and Harvard Bioscience Inc. The record holds 12 filings, for trades running from 25 February 2022 to 20 March 2026.
On the open market, the record shows 1 purchase worth €22k and 1 sale worth €6,473. Purchases outweigh sales by €15k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 10 share grants. In 2026 alone, the filings show 1 purchase and no sales.
On 1 April 2026 came the latest disclosure, a share grant in Harvard Bioscience Inc. The latest purchase dates back some time: it was published 200 days ago, on 1 April 2026. Filings reach the SEC (Form 4) feed a median of 14 days after the trade. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
12 of 12 declarations